When a caregiver manages treatment, the rivastigmine patch offers once-daily dosing with steadier tolerance than capsules but requires strict skin care and daily supervision. Rivastigmine transdermal system is a skin patch that delivers an acetylcholinesterase inhibitor, a drug that raises brain acetylcholine to ease dementia symptoms. For busy households, the appeal is practical: one patch per day, no pills to swallow, and less nausea and vomiting. The trade-off is that benefit is symptom stability for months, not a cure or halt to decline.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who Is the Patch For?
- What Did the Main Caregiver Trial Show?
- How Should a Caregiver Handle Each Day?
- What Are the Limits and Warning Signs?
Who Is the Patch For?
The patch is for mild, moderate and severe dementia of the Alzheimer type and mild-to-moderate dementia linked to Parkinson disease. The U.S. National Library of Medicine DailyMed states this approval in the current DailyMed label.
Treatment usually starts at 4.6 mg over 24 hours once daily. Maintenance is 9.5 mg over 24 hours or 13.3 mg over 24 hours, with a new patch every 24 hours. A caregiver role matters because the person with dementia often cannot track dose, site rotation, or skin changes alone. The prescriber sets the target dose and timing for increases.
What Did the Main Caregiver Trial Show?
In the 1,195-patient IDEAL trial, the 9.5-mg patch matched 12 mg per day of oral capsules on cognition and global function over 24 weeks. Managed Healthcare Executive reported the Winblad findings in its 2007 IDEAL trial report. Tolerance favored the patch.
Nausea occurred in 7.2% with the patch versus 23.1% with capsules, and vomiting in 6.2% versus 17%. Fewer stomach upsets can help a person stay on an effective dose. Caregivers also favored the routine. More than 70% preferred patch over capsules, pointing to easier use, easier schedule-following and less interference with daily life, according to Medical News Today in its 2006 caregiver-preference report.
How Should a Caregiver Handle Each Day?
Use the same time each day. Remove yesterday's patch before placing a new one, so only one patch is worn at a time. Do not reuse a skin site within 14 days.
Rotation lowers redness, itching and local irritation. Place the patch where clothing will not rub it off but where the caregiver can inspect it. Back, upper chest or upper arm often work when the person cannot reach and remove it.
- Remove the old patch and fold it closed before throwing it away.
- Place the new patch on clean, dry, intact skin at a fresh site.
- Press firmly, check edges, then wash hands.
- Write down date, time, dose and body site.
What Are the Limits and Warning Signs?
Rivastigmine treats symptoms only. The U.S. Department of Veterans Affairs dementia caregiver resource notes that drugs in this group do not cure dementia or stop progression, so the goal is often months of stability with ongoing supervision. Skin reactions are the most frequent local issue.
Watch for spreading redness, swelling, blisters, intense itching or rash beyond the patch edge, which may signal contact dermatitis. Systemic risks need prompt action. Key concerns named in DailyMed warnings include: Remove extra patches and seek emergency care for severe vomiting, fainting, slow heartbeat, chest pain, trouble breathing or collapse. Tell every clinician and pharmacist that a patch is in use before adding sleep, bladder, allergy or stomach drugs.
- Weight loss, poor appetite, nausea, vomiting or stomach pain
- Black stools, vomit that looks like coffee grounds, or ulcer signs
- Slow pulse, fainting, urinary difficulty, worsening tremor or seizures
- Signs of too much drug from more than one patch at once, which has required hospital care and rarely caused death





